---
title: "FUSHILAI raw materials have obtained the European CEP certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228156321.md"
description: "FUSHILAI announced that the company has obtained the Certificate of Suitability for European Pharmacopoeia (CEP certificate) issued by the European Medicines Agency for alpha-lipoic acid raw materials. This drug is mainly used for the treatment of diabetic polyneuropathy"
datetime: "2025-02-13T08:16:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228156321.md)
  - [en](https://longbridge.com/en/news/228156321.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228156321.md)
generator: "portal-rs"
---

# FUSHILAI raw materials have obtained the European CEP certificate

According to the Zhitong Finance APP, FUSHILAI (301258.SZ) announced that the company has received the Certificate of Suitability for European Pharmacopoeia (CEP certificate) issued by the European Directorate for Quality Medicines (EDQM) for alpha-lipoic acid raw materials. The original manufacturer of alpha-lipoic acid is STADA from Germany, which belongs to the category of vitamin compounds and is mainly used for diabetic polyneuropathy

### Related Stocks

- [301258.CN](https://longbridge.com/en/quote/301258.CN.md)

## Related News & Research

- [Wetour Robotics Shareholders Approve Major Capital Restructuring at August EGM](https://longbridge.com/en/news/296929137.md)
- [Carlsberg supervisory board member Jens Hjorth buys Carlsberg shares](https://longbridge.com/en/news/296996512.md)
- [12:30 ETAPLA HEALTH'S 42ND ANNUAL AIDS WALK LOS ANGELES RETURNS TO WEST HOLLYWOOD ON OCTOBER 18, 2026](https://longbridge.com/en/news/296940018.md)
- [Cerro de Pasco Resources publishes FY2026 annual report](https://longbridge.com/en/news/296917802.md)
- [16:00 ETCHRIS HEMSWORTH JOINS ARCHIE ROSE DISTILLING CO. AS CO-OWNER AHEAD OF U.S. LAUNCH AND GLOBAL EXPANSION](https://longbridge.com/en/news/296950819.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**